Glomerulonephritis and granulomatous vasculitis in kidney as a complication of the use of BRAF and MEK inhibitors in the treatment of metastatic melanoma: A case report

RATIONALE: BRAF and MEK inhibitors have significantly improved the prognosis of metastatic melanoma, by inhibiting both the mitogen-activated protein kinase (MAP-kinase) pathway. They are associated with infrequent adverse kidney events. Most of these are related to the use of BRAF inhibitors and in...

Descripción completa

Detalles Bibliográficos
Autores principales: Maanaoui, Mehdi, Saint-Jacques, Camille, Gnemmi, Viviane, Frimat, Marie, Lionet, Arnaud, Hazzan, Marc, Noël, Christian, Provot, François
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
5200
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484213/
https://www.ncbi.nlm.nih.gov/pubmed/28640105
http://dx.doi.org/10.1097/MD.0000000000007196

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5484213/
https://www.ncbi.nlm.nih.gov/pubmed/28640105
http://dx.doi.org/10.1097/MD.0000000000007196

Ejemplares similares